Jan 24 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2024 Dec 31, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 4.05 3.79 5.40
(+6.9 pct) (+1.6 pct) (+6.8 pct)
Operating 670 mln 794 mln 800 mln
(-15.5 pct) (+13.5 pct) (-7.5 pct)
Recurring 675 mln 811 mln 800 mln
(-16.8 pct) (+12.3 pct) (-13.8 pct)
Net 490 mln 577 mln 550 mln
(-15.1 pct) (+16.0 pct) (-13.8 pct)
EPS 116.27 yen 138.01 yen 131.26 yen
Ann Div 32.00 yen 32.00 yen
-Q2 div NIL NIL
-Q4 div 32.00 yen 32.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T